Citas bibligráficas
Lopez, C., Macuyama, D. (2022). Prevalencia del citomegalovirus en pacientes que acuden al laboratorio del hospital III Iquitos EsSalud de enero a diciembre del 2019 [Tesis, Universidad Científica del Perú]. http://hdl.handle.net/20.500.14503/1722
Lopez, C., Macuyama, D. Prevalencia del citomegalovirus en pacientes que acuden al laboratorio del hospital III Iquitos EsSalud de enero a diciembre del 2019 [Tesis]. PE: Universidad Científica del Perú; 2022. http://hdl.handle.net/20.500.14503/1722
@misc{renati/193682,
title = "Prevalencia del citomegalovirus en pacientes que acuden al laboratorio del hospital III Iquitos EsSalud de enero a diciembre del 2019",
author = "Macuyama Saavedra, Daniel",
publisher = "Universidad Científica del Perú",
year = "2022"
}
The present study was aimed at solving the following research problem: What is the prevalence of Cytomegalovirus in patients who attended the Laboratory of Hospital III Iquitos EsSalud from January to December 2019? The research objective was: To determine the prevalence of Cytomegalovirus in patients who attended the Laboratory of Hospital III Iquitos EsSalud from January to December 2019. Material and methods: This research is quantitative and retrospective, with a non-experimental, descriptive design. We worked with a sample of 274 patients who underwent the Cytomegalovirus test for the analysis of the information, the statistical package of SPSS V.24 was used. Results: The prevalence of anti cytomegalovirus was 69.71% of the patients who attended Hospital III Iquitos EsSalud, of the reactive patients according to sex in women (85.34%) and in men (14.66%); According to age, the most frequent range was from 31 to 40 years (29.32%), according to origin it was urban with (62.83%) and according to reaction the anti cytomegalovirus Ig G with (57.07%). Conclusions: The seroprevalence of anti cytomegalovirus is important through chemiluminescence, it has a reliable tool in the diagnosis of cytomegalovirus, in our research there is a high prevalence of cytomegalovirus with 69.71% of the patients who were requested the analysis.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons